News

The Prescription Drug User Fee Act date is the target date for the FDA to complete its review of the Fampridine-SR new drug application (NDA). Ron Cohen, president

According to Novagali Pharma, Catioprost is a topical ocular proprietary BAK-free formulation of latanoprost which furthermore benefits from the ocular surface protection properties of Novasorb, its patented technology

Under the commercial agreement, the Consortium will explore production of MVA85A using the ProBioGen AGE1.CR.pIXA cell line, which was developed to replace chicken embryonic fibroblasts and chicken eggs

Under the commercial agreement, the Consortium will explore production of MVA85A using the Vivalis EB66 cell line, which is derived from duck embryonic stem cells. This cell line

Initially Ocimum will service gene expression studies on the Affymetrix platform from its facility at IJsselstein, The Netherlands. Within a couple of months, it will launch the entire

As president of Takeda Global R&D, Center, US, Dr Nabulsi directs all aspects of Takeda’s US drug development activities, including the identification of new product candidates, execution of

The agreement gives Svelte Medical exclusive rights to some intellectual property related to ‘stent-on-a-wire’ delivery systems as well as non-exclusive rights to several stent designs for use on

The primary objective of this open-label study is to assess the functionality of the ARX-01 system for post-operative pain management in patients undergoing unilateral knee replacement surgery. Thomas

The entire complement of Alsius products will continue to be offered by Zoll to meet the ongoing needs of Alsius customers and their patients. This includes both the